dc.contributor.advisor | Talukder, Mesbah | |
dc.contributor.author | Bhuiyan, Tanjina Pioush | |
dc.date.accessioned | 2025-01-13T05:03:18Z | |
dc.date.available | 2025-01-13T05:03:18Z | |
dc.date.copyright | ©2023 | |
dc.date.copyright | 2023 | |
dc.date.issued | 2023-04 | |
dc.identifier.other | ID 18346030 | |
dc.identifier.uri | http://hdl.handle.net/10361/25135 | |
dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. | en_US |
dc.description | Cataloged from PDF version of thesis. | |
dc.description | Includes bibliographical references (pages 41-43). | |
dc.description.abstract | Minoxidil, mostly used as a vasodilator was first introduced as an oral drug used to treat high blood pressure. Then gradually minoxidil showed hair darkening of fine body hair as a side effect. This specific side effect led to the development of topical minoxidil. Topical minoxidil is mainly produced as a 2% solution to treat female adrenergic alopecia and a 5% solution for male adrenergic alopecia. But the changes disappeared after stopping its use for a month. Minoxidil is mainly potassium channel opener so it assumes that it causes hyperpolarization and again it's a vasodilator. The mechanism it mainly widening blood vessels and opening potassium channels so it allows more oxygen and nutrients to the hair which causes regrowth of hair. This article will show a complete review of the pharmacokinetics, pharmacodynamics, and mechanism of action, side effects, and clinical efficacy of topical minoxidil. | en_US |
dc.description.statementofresponsibility | Tanjina Pioush Bhuiyan | |
dc.format.extent | 43 pages | |
dc.language.iso | en | en_US |
dc.publisher | BRAC University | en_US |
dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission | |
dc.subject | Topical minoxidil | en_US |
dc.subject | Adrenergic alopecia | en_US |
dc.subject | Hyperpolarization | en_US |
dc.subject | Vasodilator | en_US |
dc.subject | Dihydrotestosterone | en_US |
dc.subject.lcsh | Minoxidil--Therapeutic Use. | |
dc.subject.lcsh | Androgenetic Alopecia. | |
dc.subject.lcsh | Clinical Trials--Hair Loss Treatments. | |
dc.title | A study on the efficacy of 2% and 5% topical minoxidil solution on Adrenergic Alopecia | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | School of Pharmacy, Brac University | |
dc.description.degree | B. Pharmacy | |